Genetic background as a possible determinant of clinical and biological features of Epstein-Barr virus infection - A hypothetical view

Critical Reviews in Oncology/Hematology

Volumn 44, Issue 3, 2002, Pages 217-225

  Mizutani, Shuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Ataxia telangiectasia; Cell cycle; Radiosensitivity

Indexed keywords

ATM PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN LMP1; UNCLASSIFIED DRUG;

APOPTOSIS; ATAXIA TELANGIECTASIA; B LYMPHOCYTE; CELL CYCLE; CELL LINE; CLINICAL FEATURE; CLONOGENIC ASSAY; CONFERENCE PAPER; DISEASE COURSE; DNA DAMAGE; EPITHELIUM; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC STABILITY; HETEROZYGOTE; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LYMPHOID TISSUE; PLOIDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TARGET CELL; VIRUS GENE; VIRUS INFECTION; WESTERN BLOTTING; GENETIC PREDISPOSITION; GENETICS; PATHOGENICITY; REVIEW; VIROLOGY;

ATAXIA TELANGIECTASIA; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 4, HUMAN; HUMANS;

EID: 0036900655     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(02)00113-0     Document Type: Conference Paper

References (32)

1. Cohen J.I. Epstein-Barr virus infection. N. Engl. J. Med. 343:2000;481-492.
2. Shigeta T., Takagi M., Delia D., et al. Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations. Cancer Res. 59:1999;2602-2607.
3. Takagi M., Delia D., Chessa L., et al. Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. Cancer Res. 58:1998;4923-4929.
4. Goi K., Takagi M., Iwata S., et al. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res. 57:1997;1895-1902.
5. Becker-Catania S.G., Chen G., Hwang M.J., et al. Ataxia telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol. Genet. Metab. 70:2000;122-133.
6. Huo Y.K., Wang Z., Hong J.H., et al. Radiosensitivity of ataxia telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res. 54:1994;2544-2547.
7. Sedgewick R.P., Boder E. Handbook of Clinical Neurology. 1991;Elsevier, New York.
8. Lavin M.F., Shiloh Y. The genetic defect in ataxia telangiectasia. Annu. Rev. Immunol. 15:1997;177-202.
9. Masucci G., Berkel I., Masucci M.G., et al. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia telangiectasia patients. J. Clin. Immunol. 4:1984;369-382.
10. Berkel A.I., Henle W., Henle G., et al. Response to Epstein-Barr virus (EBV) in ataxia telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Kroc. Found. Ser. 19:1985;287-300.
11. Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell. Biol. 1:2000;179-186.
12. Savitsky K., Bar S.A., Gilad S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
13. Savitsky K., Sfez S., Tagle D.A., et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4:1995;2025-2032.
14. Kastan M.B., Zhan Q., el D.W., et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell. 71:1992;587-597.
15. Canman C.E., Wolff A.C., Chen C.Y., et al. The p53-dependent G1 cell cycle checkpoint pathway and ataxia telangiectasia. Cancer Res. 54:1994;5054-5058.
16. Watters D., Khanna K.K., Beamish H., et al. Cellular localisation of the ataxia telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene. 14:1997;1911-1921.
17. Westphal C.H., Schmaltz C., Rowan S., et al. Genetic interactions between ATM and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 57:1997;1664-1667.
18. Baskaran R., Wood L.D., Whitaker L.L., et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387:1997;516-519.
19. Shafman T., Khanna K.K., Kedar P., et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 387:1997;520-523.
20. Cheng X., Cheong N., Wang Y., et al. Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in aged normal fibroblasts. Radiother. Oncol. 39:1996;43-52.
21. Liu V.F., Weaver D.T. The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells. Mol. Cell. Biol. 13:1993;7222-7231.
22. Lim D.S., Kim S.T., Xu B., et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature. 404:2000;613-617.
23. Flaggs G., Plug A.W., Dunks K.M., et al. ATM-dependent interactions of a mammalian Chk1 homolog with meiotic chromosomes. Curr. Biol. 7:1997;977-986.
24. Sanchez Y., Wong C., Thoma R.S., et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to CDK regulation through CDC25. Science. 277:1997;1497-1501.
25. Walworth N.C., Bernards R. Rad-dependent response of the Chk1-encoded protein kinase at the DNA damage checkpoint. Science. 271:1996;353-356.
26. Falck J., Mailand N., Syljuasen R.G., et al. The ATM-Chk2-CDC25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410:2001;842-847.
27. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:2001;247-254.
28. Beamish H., Williams R., Chen P., et al. Defect in multiple cell cycle checkpoints in ataxia telangiectasia postirradiation. Biol. Chem. 271:1996;20486-20493.
29. Peretz S., Jensen R., Baserga R., et al. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. USA. 98:2001;1676-1681.
30. Delia D., Mizutani S., Panigone S., et al. ATM protein and p53-serine 15 phosphorylation in ataxia telangiectasia (AT) patients and at heterozygotes. Br. J. Cancer. 82:2000;1938-1945.
31. Becker Y., Tabor E., Asher Y. Epstein-Barr virus BHRF1 gene but not the cellular protooncogene Bcl-2 is expressed in ataxia telangiectasia lymphoblastoid lines. Virus Genes. 5:1991;33-45.
32. Becker Y., Tabor E., Asher Y. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia telangiectasia patients. Leukemia. 2:(12):1988;178S-191S.